Prevalence of metabolic syndrome and the association with sociodemographic characteristics in adult population of Banja Luka
Abstract
Background/Aim. Metabolic syndrome (MS) is a cluster of metabolic and hemodynamic disorders that increase the risk of developing atherosclerotic cardiovascular diseases and type 2 diabetes mellitus. The aim of this study was to determine the prevalence of MS and its components in adult population of Banja Luka and association with sociodemographic characteristics. Methods. A total of 685 participants (348 men and 337 women), aged 18 years and over, were analyzed. The diagnosis of the MS was based on definition set by the International Diabetes Federation (IDF). Results. The prevalence of the MS was high (37.5%), slightly higher in women (38.3%) than in men (36.8%), but without statistically significant difference (p = 0.686). Prevalence of each individual component of the MS in the study group was over 30% (systolic blood pressure ≥ 130 mmHg – 42.0%; diastolic blood pressure ≥ 85 mmHg – 31.0%; triglycerides ≥ 1.7 mmol/L – 36.1%; high density lipoprotein (HDL) cholesterol ˂ 1.03 for men and ˂ 1.29 for women – 31.2%; glucose ≥ 5.6 mmol/L – 32.8%; central obesity ≥ 94 cm male and ≥ 80 cm female – 62.6%). The prevalence of the MS was not associated with gender, but with age. A number of participants increased with incresed age in the group with the MS with statistically significant difference compared to the group without the MS. The study showed an association between level of education and the MS. Low level of education was associated with the appearance of the MS with statistically significant differences (df = 3; p = 0.013). Association between level of education and the MS was shown in women (df = 3; p = 0.000), but not in men (df = 3; p = 0.883). Retirees and housewives were significantly present in the group with the MS, students and unemployed in the group without the MS, while employed participants showed no statistically significant difference. Conclusion: The MS was diagnosed in over one-third of adults in Banja Luka. Prevalence of MS was not associated with gender, but it was associated with age, level of education as well as with some categories of employment.
References
References:
Vishram JK, Borglykke A, Andreasen AH, Jeppesen J, Ibsen H, Jergensen T, et al. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Co-hort Project. PloS One 2014; 9(9): e107294
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosisand classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15(7): 539–53.
National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106(25): 3143–421.
International diabetes federation. The IDF consensus world-wide definition of the metbolic syndrome. Brussels: IDF; 2006.
Alberti K. G, Eckel R.H, Grundy S.M, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120(16): 1640–5.
Stojisavljević D. The prevalence of metabolic syndrome in adult population of the Republic of Srpska [dissertation]. Belgrade: Faculty of Medicine, University of Belgrade; 2014. (Serbian)
Ivezić – Lalić D, Bergman Marković B, Kranjčević K, Kem J, Vrdoljak D, Vučak J. Diversity of metabolic syndrome criteria in association with cardiovascular diseases – a family medicine-based investigation. Med Sci Monit. 2013; 19: 571–8.
Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534906 individuals. J Am Coll Cardiol 2011; 57(11): 1299–313.
Corbatón-Anchuelo A, Martínez-Larrad MT, Fernández-Pérez C, Vega-Quiroga S, Ibarra-Rueda JM, Serrano-Rios M, et al. Metabolic syndrome, adiponectin, and cardiovascular risk in Spain (The Segovia Study): impact of consensus societies criteria. Metab Syndr Relat Disord 2013; 11(5): 309–18.
Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the Metabolic Syndrome in the United States, 2003-2012. JAMA. 2015; 313(19): 1973–4.
Al-Daghri NM, Alkharfy KM, Al-Attas OS, Khan N, Alfawaz HA, Alghanim SA, et al. Gender-dependent associations be-tween socioeconomic status and metabolic syndrome: a cross-sectional study in the adult Saudi population. BMC Car-diovasc Disord 2014; 14: 51.
Khan RJ, Gebreab SY, Sims M, Riestra P, Xu R, Davis SK. Prevalence, associated factors and heritabilities of metabolic syndrome and its individual components in African Americans: the Jackson Heart Study. BMJ Open 2015; 5(10): e008675.
Vidigal F de C, Ribeiro AQ, Babio N, Salas-Salvado J, Bressan J. Prevalence of metabolic syndrome and pre-metabolic syn-drome in health professionals: LATINMETS Brazil study. Di-abetol Metab Syndr 2015; 7: 6.
Kaur J. Assessment and Screening of the Risk Factors in Meta-bolic Syndrome. Med Sci 2014; 2(3): 140 ̶ 52.
Hajian-Tilaki K, Heidari B, Firouzjahi A, Baqherzadeh M, Hajian-Tilaki A, Halalkhor S. Prevalence of metabolic syndrome and the associated socio-demographic characteristics and physical activity in urban population of Iranian adults: a population-based study. Diabetes Metab Syndr 2014; 8(3): 170–6.
Song QB, Zhao Y, Liu YQ, Zhang J, Xin SJ, Dong GH. Sex difference in the prevalence of metabolic syndrome and cardiovascular related risk factors in urban adults from 33 communities of China: The CHPSNE study. Diab Vasc Dis Res 2015; 12 (3): 189–98.